Trial Design, Measurement, and Analysis of Clinical Investigations
Authors:
- Timothy BeukelmanTBTimothy Beukelman
- Hermine I. BrunnerHBHermine I. Brunner
- 1 January 2016
- book chapter
- Published by Elsevier
- p. 54-77.e2
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood‐onset systemic lupus erythematosus disease activityArthritis & Rheumatism, 2009
- Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus ErythematosusThe Journal of Rheumatology, 2009
- The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: A propensity score analysisArthritis Care & Research, 2008
- A literature review on off-label drug use in childrenEuropean Journal of Pediatrics, 2005
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-valuesBioinformatics, 2003
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Psychometric considerations in evaluating health-related quality of life measuresQuality of Life Research, 1993
- Statistical Concepts Fundamental to InvestigationsNew England Journal of Medicine, 1985
- Bias in analytic researchJournal of Chronic Diseases, 1979